According to previous studies, the VEGFR-1 was found to be preferentially expressed in bone marrow samples and cell lines from ALL, whereas the VEGFR-2 was expressed mainly in AML cells [274,275,276]. Here, FLT1 is linked to acute myeloid leukemia.